References [1] National Library of Medicine, Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, Chang, C., Tsai, W, Hsu, Y, Pang, J.S., 2014 [2] National Library of Medicine, Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review, Vasireddi, N., Hahamyan, H., Salata, M., Karns, M., Calcei, J., Voos, J., Apostolakos, J., July 2025 [3] National Library of Medicine, Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts, Chang, C., Tsai, W., Hsu, Y., Pang, JS., November 2014
Many patients experience reduced hunger and improved portion control within the first few weeks of treatment
If you have OSA, ask your doctor if FDA-approved Zepbound might be a better fit
If you follow your treatment plan and don't lose weight, you'll receive a full refund
Ozempic Prescribing Information HCPs and patients often use the Ozempic Prescribing Information (Injection) or Ozempic Tablet Prescribing Information for more detailed information about this medicine